Active	Status	Sponsor type	Region	Phase	Filter
5 Active 3 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Torres, Antonio
POLAR, NCT03820830 / 2018-003553-19: Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer	Recruiting	3	400	Europe	Palbociclib 125mg, Ibrance, PD-0332991, Standard endocrine therapy	ETOP IBCSG Partners Foundation, Pfizer	Breast Cancer Recurrent	01/25	11/27
NCT05322122: Creation of Side-to-Side Compression Anastomosis Using the Magnetic Anastomosis System	Completed	N/A	49	Europe, Canada, RoW	Side-to-side anastomosis duodeno-ileostomy diversion procedure, The MAGNET System	GT Metabolic Solutions, Inc.	Obesity	06/23	04/24
Calvo, Mª Carmen Martín
No trials found
Peña, Sebastian
No trials found
Arjona-Sanchez, Alvaro
No trials found
Ortiz, Lidia Rodriguez
No trials found